Not applicableAvailableNCT04159597What this trial is testingExpanded Access to UpadacitinibWho this might be right forCrohn DiseaseUlcerative ColitisIdiopathic Arthritis (Including sJIA, pJIA, or JPsA)+1 more AbbVie
Not applicableStudy completedNCT02615561What this trial is testingCuring Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic ProductWho this might be right forDermatitis, Atopic Bayer 136
Not applicableUnknownNCT06213688What this trial is testingInvolvement of Pollutants in Atopic Dermatitis and PsoriasisWho this might be right forPsoriasisAtopic Dermatitis Assistance Publique Hopitaux De Marseille 64
Early research (Phase 1)Study completedNCT00891709What this trial is testingLEO 29102 Single and Multiple Dose Study by Dermal ApplicationWho this might be right forAtopic Dermatitis LEO Pharma 64
Post-approval studies (Phase 4)Study completedNCT00121316What this trial is testingSafety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) PatientsWho this might be right forAtopic Dermatitis Novartis 200
Not applicableEnded earlyNCT00295737What this trial is testingEffect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent AsthmaWho this might be right forAtopyRhinitisBronchial Asthma Fraunhofer-Institute of Toxicology and Experimental Medicine 8
Testing effectiveness (Phase 2)Study completedNCT06058000What this trial is testingQLM3003 Ointment in Participants With Mild or Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Qilu Pharmaceutical Co., Ltd. 120
Not applicableLooking for participantsNCT06319781What this trial is testingA Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or VitiligoWho this might be right forAlopecia AreataVitiligoAtopic Dermatitis+1 more Blueskin AS 370
Not applicableActive Not RecruitingNCT03687359What this trial is testingObservational Evaluation of Atopic Dermatitis in Pediatric PatientsWho this might be right forDermatitis Atopic Sanofi 1,860
Testing effectiveness (Phase 2)Study completedNCT01299610What this trial is testingTest the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a PlaceboWho this might be right forDermatitis, Atopic GlaxoSmithKline 25
Not applicableStudy completedNCT04541810What this trial is testingOral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic ArthritisWho this might be right forRheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more AbbVie 2,369
Early research (Phase 1)Study completedNCT02148744What this trial is testingSafety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisWho this might be right forAllergic RhinitisAllergic ConjunctivitisAtopic Dermatitis Xencor, Inc. 72
Not applicableLooking for participantsNCT05635266What this trial is testingTissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesWho this might be right forAge-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more Sanguine Biosciences 20,000
Not applicableLooking for participantsNCT04014413What this trial is testingSafety and Efficacy of Fecal Microbiota TransplantationWho this might be right forCrohn DiseaseUlcerative ColitisCeliac Disease+24 more Chinese University of Hong Kong 450
Testing effectiveness (Phase 2)Study completedNCT05127421What this trial is testingRuxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis InvolvementWho this might be right forAtopic Dermatitis Incyte Corporation 77
Testing effectiveness (Phase 2)Ended earlyNCT03809663What this trial is testingA Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic DermatitisWho this might be right forAtopic Dermatitis Amgen 251
Not applicableActive Not RecruitingNCT06169527What this trial is testingA Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving DupilumabWho this might be right forAtopic Dermatitis Sanofi 303
Not applicableLooking for participantsNCT04173442What this trial is testingPost-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected PregnancyWho this might be right forAtopic Dermatitis (AD)Asthma Regeneron Pharmaceuticals 500
Not applicableStudy completedNCT05019209What this trial is testingSkin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis PatientsWho this might be right forAtopic DermatitisHouse Dust Mite Allergy Fraunhofer-Institute of Toxicology and Experimental Medicine 23
Not applicableStudy completedNCT00710489What this trial is testingPotential Research Study Participant RegistryWho this might be right forAcneActinic KeratosisDysplastic Nevi+7 more University of California, Davis 265